We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

81 hedge funds and large institutions have $235M invested in Nautilus Biotechnolgy in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

529% more call options, than puts

Call options by funds: $2.04M | Put options by funds: $324K

85% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 13

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

14.95% more ownership

Funds ownership: 33.02% → 47.97% (+15%)

13% more funds holding

Funds holding: 72 → 81 (+9)

4% less capital invested

Capital invested by funds: $245M → $235M (-$10.3M)

Holders
81
Holders Change
+9
Holders Change %
+12.5%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
22
Increased
24
Reduced
13
Closed
13
Calls
$2.04M
Puts
$324K
Net Calls
+$1.71M
Net Calls Change
+$1.02M

Top Buyers

Rank Fund Capital Flow
1
AI
ArchPoint Investors
Florida
+$7.76M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.74M
3
TM
Tikvah Management
North Carolina
+$2.8M
4
CGL
Clarius Group LLC
Washington
+$2.19M
5
PA
Perceptive Advisors
New York
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$4.91M
2
BC
Boxer Capital
California
-$4.61M
3
APM
Avidity Partners Management
Texas
-$3.68M
4
SCM
Suvretta Capital Management
New York
-$1.93M
5
ABG
Ally Bridge Group
New York
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$47.2M +$1.07M +200,000 +2%
MVG
2
Madrona Venture Group
Washington
$31.2M – – –
AEPBI
3
AH Equity Partners Bio II
California
$16.3M +$87.2M +16,298,006 New
RCM
4
RA Capital Management
Massachusetts
$12.6M – – –
CFM
5
Comprehensive Financial Management
California
$11.5M – – –
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
$10.4M – – –
ACI
7
Amazon.com Inc
Washington
$7.55M – – –
O
8
OrbiMed
New York
$7.53M – – –
AI
9
ArchPoint Investors
Florida
$7.51M +$7.76M +1,449,551 New
Franklin Resources
10
Franklin Resources
California
$7.38M -$402K -75,018 -5%
Vanguard Group
11
Vanguard Group
Pennsylvania
$6.66M +$3.74M +699,435 +119%
BlackRock
12
BlackRock
New York
$6.49M +$126K +23,560 +2%
TM
13
Tikvah Management
North Carolina
$6.38M +$2.8M +523,295 +74%
ABG
14
Ally Bridge Group
New York
$6.35M -$1.47M -274,940 -18%
RI
15
RTW Investments
New York
$5.7M – – –
AAA
16
Affinity Asset Advisors
New York
$5.44M +$400K +74,721 +8%
NCM
17
Nantahala Capital Management
Connecticut
$5.33M -$77K -14,395 -1%
SFM
18
Sphera Funds Management
Israel
$4.14M – – –
RCMNY
19
Rubric Capital Management (New York)
New York
$3.87M – – –
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$2.57M – – –
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.56M +$585K +109,327 +28%
CGL
22
Clarius Group LLC
Washington
$2.21M +$2.19M +408,663 +2,238%
BOTOTLSJU
23
Board of Trustees of The Leland Stanford Junior University
California
$1.6M – – –
BM
24
Bridger Management
New York
$1.5M +$872K +163,000 +129%
AEPLI
25
AH Equity Partners LSV II
California
$1.36M +$7.26M +1,355,911 New
1
2 3 4

NAUT Hedge Fund Activity: Q4 2021 in Review

81 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q4 2021, worth a combined $235M — down 4.2% from $245M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NAUT positions and 13 closed out — a net gain of 9 holders — while 24 added to existing stakes and 13 trimmed.

The largest buyer was ArchPoint Investors, opening a new position worth an estimated $7.76M. The largest seller was Federated Hermes, exiting entirely with an estimated $4.91M sold.

  • 81 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q4 2021, up from 72 in Q3 2021.
  • Funds reported $235M of Nautilus Biotechnolgy stock for Q4 2021, down 4.2% quarter-over-quarter.
  • 22 funds opened new Nautilus Biotechnolgy positions in Q4 2021 and 13 closed out, a net change of +9 holders.
  • The largest Nautilus Biotechnolgy buyer in Q4 2021 was ArchPoint Investors, an estimated $7.76M added.
  • The largest Nautilus Biotechnolgy seller in Q4 2021 was Federated Hermes, an estimated $4.91M sold.

Based on aggregated 13F filings for Q4 2021.